Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancer
about
Curcumin AntiCancer Studies in Pancreatic CancerCancer of the Pancreas: Molecular Pathways and Current Advancement in TreatmentThe Role of microRNAs in the Diagnosis and Treatment of Pancreatic AdenocarcinomaCancer Stem Cells: The Potential Targets of Chinese Medicines and Their Active CompoundsMicroRNA Targeted Therapeutic Approach for Pancreatic CancerThe critical roles of miR-21 in anti-cancer effects of curcuminTargeting colorectal cancer stem cells using curcumin and curcumin analogues: insights into the mechanism of the therapeutic efficacyPhytochemicals modulate carcinogenic signaling pathways in breast and hormone-related cancersPerspectives on new synthetic curcumin analogs and their potential anticancer propertiesPancreatic cancer stem cells: emerging target for designing novel therapyThe role of cancer stem cells and miRNAs in defining the complexities of brain metastasisTargeting CSC-related miRNAs for cancer therapy by natural agentsThe miR-200 and miR-221/222 microRNA families: opposing effects on epithelial identityMicroRNAs as targets for dietary and pharmacological inhibitors of mutagenesis and carcinogenesisClinical advances in molecular biomarkers for cancer diagnosis and therapyConcise Review: Stem Cells in Pancreatic Cancer: From Concept to TranslationHypoxia-induced aggressiveness of pancreatic cancer cells is due to increased expression of VEGF, IL-6 and miR-21, which can be attenuated by CDF treatment3, 3'-Diindolylmethane enhances the effectiveness of herceptin against HER-2/neu-expressing breast cancer cellsProstate cancer stem cell-targeted efficacy of a new-generation taxoid, SBT-1214 and novel polyenolic zinc-binding curcuminoid, CMC2.24Difluorinated-curcumin (CDF) restores PTEN expression in colon cancer cells by down-regulating miR-21Curcumin intake affects miRNA signature in murine melanoma with mmu-miR-205-5p most significantly alteredMicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells.Sweating the small stuff: microRNAs and genetic changes define pancreatic cancer.Deregulation of miR-146a expression in a mouse model of pancreatic cancer affecting EGFR signaling.Curcumin: a potential candidate in prevention of cancer via modulation of molecular pathways.microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer.Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT/ERK1/2 inactivation by targeting PTENHypoxia induced aggressiveness of prostate cancer cells is linked with deregulated expression of VEGF, IL-6 and miRNAs that are attenuated by CDF.Network modeling of CDF treated pancreatic cancer cells reveals a novel c-myc-p73 dependent apoptotic mechanism.Genetic and molecular alterations in pancreatic cancer: implications for personalized medicine.The Role of Nutraceuticals in Pancreatic Cancer Prevention and Therapy: Targeting Cellular Signaling, MicroRNAs, and Epigenome.Reduced expression of miR-200 family members contributes to antiestrogen resistance in LY2 human breast cancer cellsmiR-150-5p inhibits hepatoma cell migration and invasion by targeting MMP14.MiR-200a inhibits epithelial-mesenchymal transition of pancreatic cancer stem cell.Potential applications of curcumin and its novel synthetic analogs and nanotechnology-based formulations in cancer prevention and therapy.MicroRNAs, diet, and cancer: new mechanistic insights on the epigenetic actions of phytochemicals.Inflammaging and cancer: a challenge for the Mediterranean dietManipulating miRNA Expression: A Novel Approach for Colon Cancer Prevention and ChemotherapyPancreatic cancer tumour initiating cells: the molecular regulation and therapeutic valuesInactivation of Ink4a/Arf leads to deregulated expression of miRNAs in K-Ras transgenic mouse model of pancreatic cancer.
P2860
Q26738714-54FFCAE6-25CD-4CB4-911E-E8E4D0CDE5A2Q26740619-FFF7C1AA-1CFF-424F-8A5F-AA80D5B40CA6Q26744298-8204B200-76F5-4CE4-B085-CAE847C38A54Q26747518-D14F5CCC-705D-4362-A102-B6611A02B474Q26765233-96B58D6B-B701-4B67-9435-19FBBC96EE33Q26770490-C34FE3EE-5A11-43BA-A7F5-2A8E22BFE1AEQ26784365-4CEC5005-1D8A-4D5C-8048-9C5226DC6C69Q26798324-A58014F7-8B17-4E51-94B1-EC1578E759E7Q26851248-345CAAB6-AB25-4C48-8705-C41A46035A80Q26863365-813B646A-3F42-49A6-8544-1A763CE70CA3Q26864372-52BAC3BE-7EFD-427B-A0AD-F04429992FA3Q27003230-A1B01AD2-622D-454A-9CDD-1A0D23D7D544Q27010233-E640830D-A534-44F4-B1ED-5639521A1105Q27011401-91630AD4-02D5-4CFA-9FCF-9E076151FC73Q27027560-0BF1DBFB-7D3F-471E-98AC-660EFE7C1E4EQ28081553-5CFBB0DE-D114-43E6-83A3-CD535AC7869BQ28484357-27E51890-FA37-47D9-BBC5-D2908218ACBCQ28485231-4C00F7F9-3F52-4E84-BC04-AD45E23B97FFQ28533786-AA4334CA-C0E9-4AD4-B68F-9D7133A5AC25Q28534834-7E100783-3F9E-493F-AA5C-A73C505A215AQ28537584-5B06E02C-2359-4404-9F77-F2900E94B3BCQ30010065-AC28D677-734A-4F8B-975D-41C806A5EAB8Q33862088-8BC505AA-D0E9-4F9E-AED6-4CDA593DAA88Q33970228-2F667922-5058-4829-AD63-AE4AFB4DA6F4Q34252516-836B19FE-2D88-43C2-9142-EE4D96ACADC0Q34312916-66ED25BB-5D8D-454B-9F93-B5AFE510AA23Q34326206-B9A0DB61-74C0-47A7-8277-92EC72EDA8E9Q34405506-4A36140F-7CBD-4737-BB28-A098B5C1BA20Q34632154-A6786189-C303-4393-B362-B9D8ECE0D984Q34657038-6308ECB8-C4CD-4B5F-BDE4-8DFAF78138A2Q34690409-896786CD-B140-4B6A-9CFD-6996B5207CBFQ34693000-F3CBEB74-23A0-4655-A649-E42C60469E7EQ34790217-8F90C1D2-C8BC-4974-86E4-C6571D8789F2Q35093171-202EFF6A-26CD-4919-BA73-3C2F439799D2Q35225869-80DD15AF-E51C-49F9-8893-47BF284DDD20Q35388050-2C78192C-F839-476F-BE27-560BCE7B489AQ35585943-9400B745-FC29-485A-87BD-9E46198F3C8CQ35647187-F059C924-C7E1-47B2-B472-AE0EF083BAA0Q35819328-EC713292-A8C0-45AE-B5EB-40BECA81085AQ35881608-3E1F8094-CBC1-44CC-A71A-42C4AFC7B637
P2860
Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancer
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Anti-tumor activity of a novel ...... and PTEN in pancreatic cancer
@ast
Anti-tumor activity of a novel ...... and PTEN in pancreatic cancer
@en
Anti-tumor activity of a novel ...... and PTEN in pancreatic cancer
@nl
type
label
Anti-tumor activity of a novel ...... and PTEN in pancreatic cancer
@ast
Anti-tumor activity of a novel ...... and PTEN in pancreatic cancer
@en
Anti-tumor activity of a novel ...... and PTEN in pancreatic cancer
@nl
prefLabel
Anti-tumor activity of a novel ...... and PTEN in pancreatic cancer
@ast
Anti-tumor activity of a novel ...... and PTEN in pancreatic cancer
@en
Anti-tumor activity of a novel ...... and PTEN in pancreatic cancer
@nl
P2093
P2860
P3181
P1433
P1476
Anti-tumor activity of a novel ...... and PTEN in pancreatic cancer
@en
P2093
Amro Aboukameel
Dejuan Kong
Fazlul H Sarkar
Philip A Philip
Sanila H Sarkar
Sanjeev Banerjee
Shadan Ali
Subhash Padhye
Zhiwei Wang
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0017850
P407
P577
2011-03-09T00:00:00Z